Lipids & Cardiovascular Protection

Of 7,260 HDL results Loop ran on urban working professionals in the latest 12-month window, 44.0% sit below 40 mg/dL — the level at which the blood carries effectively no protective cholesterol — down from 47.7% in WHI 2025 on a sample more than four times smaller. Low HDL is the earliest lipid marker to fail and the one routine screening is most likely to wave through. The Global Burden of Disease work places ischaemic heart disease as the leading cause of death in India, with onset roughly a decade earlier than in higher-income populations (Prabhakaran et al., Circulation, 2016). The HDL deficit on this page is the population sitting upstream of that statistic, mostly unaware and mostly unmedicated — the same metabolic cluster the Blood Sugar page surfaces from the glucose side, presenting here on the lipid panel.

HDL is not the marker a cardiologist treats first. LDL is. But HDL is the marker that fails first and quietly, and on this panel it fails in almost half the workforce.

One in twenty professionals tested reaches a protective HDL level. The population average is 42.06 mg/dL — inside the "critically low to borderline" zone, not above it. The centre of the distribution sits where a clinician would want only the worst tail to sit.

The headline rate fell, but the construct it measures didn't improve#

The strict-low rate dropped 3.7 points and the male rate dropped 5.2. The female rate held flat. The drop is real in the data, but the construct underneath it has not changed: the population still centres below the protective line, and the marker that drives the year-on-year movement — strict HDL <40 — is the same marker that systematically under-counts women. The headline fell partly because the 2026 sample includes more women, and women clear the strict 40 mg/dL bar more often than men while still failing the threshold that actually applies to them.

The strict threshold hides most of the risk in women#

Apply one threshold to everyone and men look far worse off than women — 54.0% against 31.4%, a 22.6-point gap. Apply the threshold each gender's physiology requires, and the picture inverts: 70.4% of women fall short, against 54.0% of men. The strict cutoff does not measure women's cardiovascular protection. It measures whether women clear a bar set for men, and most of them do — while still sitting below the bar set for them.

The clinical implication is direct. A lipid panel scored against a single 40 mg/dL line will reassure roughly four in ten women whose HDL is genuinely below protective. The gender-correct cutoff is not a refinement; it is the difference between flagging the deficiency and missing it.

A normal cholesterol reading misses the most common deficiency#

Total cholesterol is the number most people remember from a checkup, and the one most likely to read "normal." It is also the least informative line on the lipid panel. Among the 5,163 reports with a total cholesterol below 200 mg/dL — the textbook safe range — 47.3% still have HDL below 40. A normal total reading and a low HDL coexist routinely, because total cholesterol sums HDL, LDL and a triglyceride term, and a person can land in range while the protective fraction is depleted.

LDL risk is the broadest of all and peaks in the 40s#

The page leads with HDL because it fails first and gets missed. But the marker the heart-disease evidence treats as causal is LDL, and on LDL the workforce is in worse aggregate shape than on any other lipid line.

62.6% of tested professionals have LDL at or above 100 mg/dL, the optimal ceiling, and more than one in four sits in the high or very-high bands above 130. Where HDL declines with the strict cutoff misleading at the edges, LDL rises cleanly with age and peaks in mid-career:

LDL crosses 70% in the 40s — the decade with the highest share of professionals carrying elevated bad cholesterol. The decline after 60 is partly survivorship and partly the wider use of statins in older patients; it is not the workforce getting healthier with age. Triglycerides follow the same arc, rising from 23.1% elevated in the 20s to 40.2% in the 50s, with a sharp male skew — 40.7% of men against 23.6% of women.

Hyderabad has the weakest cardiac protection of the metros#

Hyderabad sits highest on strict-low HDL at 50.6% — its single worst biomarker, and the one the Hyderabad city page leads on — with Pune and Mumbai close behind. The metro spread is real but narrow — every major city sits between 39% and 51% — which is itself the finding. Low HDL is not a city problem the way Delhi's liver dysfunction or Mumbai's glucose burden are city problems. It is uniform. The cardiovascular-protection deficit is the most evenly distributed biomarker failure in the 2026 dataset.

Within the cities, the female HDL story stays consistent with the national pattern. Mumbai women remain the worst-protected city cohort: 78.1% sit below the 50 mg/dL female threshold (n=442), against 73.5% in Hyderabad and 72.9% in Pune.

The dependent gap runs the opposite way on HDL — because of who the dependents are#

On blood sugar, dependents are 20 points worse than employees. On strict-low HDL, the direction reverses: dependents look 10 points better. The reversal is not health — it is arithmetic. The strict 40 mg/dL cutoff under-counts women, and the dependent pool is far more female than the employee pool. Split by gender and the apparent dependent advantage dissolves:

Hold gender constant and dependents and employees sit within three points of each other in both columns. The dependent layer is not better protected. It is differently composed — more women, scored against a threshold that lets women through. The same masking that hides women's risk at the national level manufactures a false reassurance about the dependent population.

What the lipid panel says, in one line#

Two-thirds of the tested workforce has elevated LDL, and — scored honestly — three in five lack protective HDL. The marker that fails first and gets missed is HDL; the marker that drives disease is LDL; the workforce is in the wrong band on both. The headline rate fell this year, but only the ruler changed, not the blood.